H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes
Authors
Keywords
-
Journal
Epigenomics
Volume 8, Issue 7, Pages 909-924
Publisher
Future Medicine Ltd
Online
2016-07-18
DOI
10.2217/epi-2016-0015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A bivalent role of TIP60 histone acetyl transferase in human cancer
- (2015) Gaëlle Judes et al. Epigenomics
- The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
- (2015) Marjolaine Ngollo et al. BMC CANCER
- An Object-Oriented Framework for Robust Multivariate Analysis
- (2015) Valentin Todorov et al. Journal of Statistical Software
- Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study
- (2014) Megan A. Healey et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes
- (2014) Yongsheng Li et al. HUMAN MOLECULAR GENETICS
- Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives
- (2014) Felipe Ades et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast tumor subgroups reveal diverse clinical prognostic power
- (2014) Zhaoqi Liu et al. Scientific Reports
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents
- (2013) H. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines
- (2013) Aslihan Dagdemir et al. Epigenomics
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- H3 Lysine 4 Is Acetylated at Active Gene Promoters and Is Regulated by H3 Lysine 4 Methylation
- (2011) Benoit Guillemette et al. PLoS Genetics
- Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer
- (2010) Katrina Bauer et al. BMC CANCER
- A chromodomain switch mediated by histone H3 Lys 4 acetylation regulates heterochromatin assembly
- (2010) B. Xhemalce et al. GENES & DEVELOPMENT
- The Expression of H3K9Ac, H3K14Ac, and H4K20TriMe in Epithelial Ovarian Tumors and the Clinical Significance
- (2010) Li Zhen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular Biology of Breast Tumor Progression: A View From the Other Side
- (2010) Stuart J. Schnitt INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Transcriptional regulation of BRCA1 expression by a metabolic switch
- (2010) Li-Jun Di et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations
- (2009) M. M. Gaudet et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
- (2009) S. E. Elsheikh et al. CANCER RESEARCH
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- The role of SRC-3 in human breast cancer
- (2009) Ondrej Gojis et al. Nature Reviews Clinical Oncology
- Epigenetic Cross-Talk between DNA Methylation and Histone Modifications in Human Cancers
- (2009) Yutaka Kondo YONSEI MEDICAL JOURNAL
- Combinatorial patterns of histone acetylations and methylations in the human genome
- (2008) Zhibin Wang et al. NATURE GENETICS
- DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression
- (2008) B. Perillo et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation